Request a copy of the file
Enter the following information to request a copy for the following item: Place de la canagliflozine (Invokana®), un nouvel inhibiteur SGLT2 dans le traitement du diabète de type 2
Requesting the following file: 2014_Buysschaert_Louvain_Medical.pdf